Yes, women starting testosterone replacement therapy can develop acne—sometimes significantly—even later in life at 60 or beyond. The medical data shows that acne emerges as a side effect in 30 to 70 percent of TRT patients, with onset typically occurring within 3 to 12 months of beginning treatment. What makes this concerning is that some physicians do not adequately discuss this dermatological risk before starting patients on testosterone, leaving women unprepared for a visible skin condition that can deeply affect self-image and quality of life. This article examines what the medical evidence shows about acne from testosterone therapy, why doctors should warn patients, what treatment options exist, and how women can advocate for their skin health when starting HRT.
Table of Contents
- Why Does Testosterone Replacement Therapy Cause Acne in Women?
- The Doctor-Patient Communication Gap: Why Warnings Often Don’t Happen
- How Quickly Does Acne Appear After Starting TRT?
- Treatment Options: What Actually Works for TRT-Induced Acne
- Acne Severity and Scarring Risk: Why Earlier Intervention Matters
- Evaluating Testosterone Lawsuits and What They Cover
- Moving Forward: Advocacy and Informed Care
- Conclusion
- Frequently Asked Questions
Why Does Testosterone Replacement Therapy Cause Acne in Women?
Testosterone is an androgen—a hormone that stimulates the sebaceous (oil) glands in the skin. When women begin TRT, testosterone levels rise above pre-treatment baseline, which increases sebaceous gland activity and sebum (oil) production. Excess sebum clogs hair follicles, creating an environment where bacteria thrive and inflammation develops, resulting in comedones, pustules, and cystic acne. This mechanism is not hypothetical; it’s documented in dermatology literature and occurs regardless of age. A woman starting testosterone at 60 experiences the same hormonal trigger as a younger patient—her skin glands respond to the hormone by increasing oil production.
The data on prevalence is striking. In clinical trials of testosterone products, acne appeared as an adverse dermatologic effect in 0.6 percent to 9.1 percent of users. However, in broader patient populations and real-world use, the rate climbs to 30 to 70 percent. This gap between trial data and actual practice suggests that acne may be underreported in controlled studies or that open-label, longer-term use reveals higher incidence. Among transmasculine and transgender patients receiving testosterone, facial acne increased from 35 percent pre-treatment to 82.4 percent post-treatment—one of the most dramatic adverse skin effects documented.
The Doctor-Patient Communication Gap: Why Warnings Often Don’t Happen
Many physicians prescribing testosterone for menopausal or hypogonadal women focus primarily on major health risks—cardiovascular events, stroke, heart attack—because those carry the highest morbidity and mortality. The FDA warning issued in 2016 on testosterone products emphasized cardiovascular dangers, which has shaped clinical conversation around TRT safety. Acne, while not life-threatening, is sidelined as a “cosmetic” concern, even though it can cause significant psychological distress, impact social functioning, and sometimes lead to scarring if left untreated or managed poorly.
The result is a communication failure: women arrive at their dermatologist—if they even make that connection—after acne has already developed, sometimes surprised and frustrated that no one mentioned this possibility. This is especially true for women over 50 or 60, who may not expect hormonal acne to be an issue at their age and therefore don’t ask about it. A physician who says, “You may develop acne within a few months, and here’s how we’ll manage it,” sets entirely different expectations than silence followed by skin problems.
How Quickly Does Acne Appear After Starting TRT?
Acne from testosterone is not immediate. Medical literature indicates that acne typically emerges within 3 to 12 months of starting TRT. This timing window is important because it means a woman starting testosterone at age 60 might not see skin changes for several months—by which point she may have adjusted her dose, and the connection between the therapy and the acne may not be obvious. Some women experience onset within weeks; others take the full year. This variability means that even with a warning, individual responses
Treatment Options: What Actually Works for TRT-Induced Acne
The good news is that acne from testosterone is treatable. Standard dermatological approaches include topical treatments (benzoyl peroxide, salicylic acid, retinoids, topical antibiotics), oral antibiotics (doxycycline, minocycline), and hormonal anti-androgens. For women specifically, spironolactone—a potassium-sparing diuretic with anti-androgenic properties—is an evidence-based option that can reduce sebum production and acne severity without stopping testosterone therapy. The American Academy of Dermatology acknowledges acne management in transgender and gender-affirming testosterone therapy as a legitimate clinical concern with established treatment protocols.
The critical distinction is that acne from TRT does not necessarily require stopping testosterone. Many women continue their hormone therapy while treating the acne concurrently. A physician can adjust TRT dosage, monitor skin response, and add anti-acne medications in parallel. However, if a woman is not warned beforehand and develops severe acne, she may make hasty decisions—stopping TRT abruptly or giving up on treatment—without exploring these options. Informed decision-making requires upfront knowledge.
Acne Severity and Scarring Risk: Why Earlier Intervention Matters
While some women develop mild comedonal or pustular acne from TRT, others experience severe cystic acne that leaves permanent scarring if left untreated. The longer acne persists before treatment begins, the higher the risk of atrophic (pitted) or hypertrophic (raised) scars. For a woman who did not expect acne at 60 and did not seek treatment immediately, the delay between onset and intervention could mean the difference between temporary inflammation and lasting skin damage.
This risk is not theoretical. Dermatologists routinely see patients who wished they had started acne treatment sooner. The preventive mindset—knowing acne is coming and having a treatment plan ready—is far more effective than reactive treatment after months of untreated lesions. This is another reason that physician disclosure and preparedness matter: they allow for proactive intervention that preserves skin.
Evaluating Testosterone Lawsuits and What They Cover
The major testosterone-related lawsuits in the United States have focused on cardiovascular complications—strokes and heart attacks—rather than acne or other dermatological effects. AbbVie settled approximately 4,200 AndroGel cases as of September 2018, but these suits centered on inadequate cardiovascular risk disclosure, not skin side effects.
If a woman develops acne from TRT and suffers psychological harm or scarring, her legal recourse is limited because acne is not currently the subject of major product liability litigation. This gap in litigation does not mean acne is not a legitimate adverse effect; it reflects the medical and legal system’s prioritization of life-threatening conditions. However, it underscores why individual physician accountability—through informed consent and proper counseling—is the primary mechanism of patient protection regarding acne risk from TRT.
Moving Forward: Advocacy and Informed Care
The future of TRT management should include routine, transparent discussion of dermatological side effects alongside cardiovascular and other systemic risks. Women starting testosterone, regardless of age, deserve to know that acne is a common possibility, when to expect it, and what treatment options exist.
This conversation need not discourage testosterone therapy; it simply enables informed consent and proactive skin management. For women already on TRT who have developed acne, the path forward involves consulting a dermatologist who understands hormone-driven acne, exploring the treatment options above, and communicating with the prescribing physician about whether dose adjustment, medication timing, or other modifications might help. Acne from testosterone is preventable in impact if addressed early—which is precisely why physician warning and patient education matter.
Conclusion
Women starting testosterone replacement therapy at any age, including at 60, are at risk for developing acne as a hormonal side effect. The incidence is substantial—30 to 70 percent of TRT patients—and acne typically emerges within 3 to 12 months. The failure of some physicians to warn patients about this risk, while focusing exclusively on cardiovascular concerns, leaves women unprepared and potentially allows treatable acne to progress to scarring before intervention begins. Acne from TRT is not inevitable and is manageable with topical treatments, oral antibiotics, anti-androgens like spironolactone, and dose adjustments; the key is early recognition and timely management.
If you are considering TRT or are already on testosterone and developing acne, prioritize a conversation with your prescribing physician about acne risk and have a dermatology referral ready. Ask directly whether acne is a recognized side effect and what the treatment plan would be if it develops. Advocate for your skin as you advocate for your hormonal health—they are not separate concerns. An informed patient, supported by a communicative physician and a responsive dermatologist, can navigate TRT without allowing acne to become a lasting problem.
Frequently Asked Questions
Can I stop testosterone if acne develops?
No, you do not have to stop TRT to treat acne. Acne can be managed with dermatological treatments while continuing hormone therapy. Discuss with both your endocrinologist and dermatologist about concurrent management rather than discontinuing TRT.
How long does acne from testosterone last after I stop treatment?
Acne typically resolves within a few weeks to months after discontinuing TRT, as testosterone levels return to baseline. However, any scarring that developed beforehand will be permanent, which is why early treatment is important.
Is acne from TRT different from regular acne?
The underlying cause is different—androgen-driven increased sebum production—but the appearance and treatment approach are similar to other acne. However, hormonal anti-androgens like spironolactone are particularly effective for TRT-induced acne and may not be appropriate for other acne types.
Can my dermatologist and hormone doctor work together on this?
Yes, and they should. Inform both providers that you are on TRT and that you are developing acne. They can coordinate on whether dose adjustment, topical treatment, oral antibiotics, or anti-androgenic medications are most appropriate for your situation.
At age 60, should I expect more or less severe acne from TRT than a younger person?
Age does not necessarily protect you from TRT-induced acne; both younger and older women experience it. Your skin responds to hormonal changes regardless of age. However, older skin may heal more slowly, making early prevention even more important.
What if my doctor refuses to discuss acne as a side effect?
Request a referral to a dermatologist who specializes in hormonal acne or gender-affirming care. Document your concerns in writing to your prescribing physician. You have the right to informed consent, which includes discussing known side effects, even if they are not life-threatening.
You Might Also Like
- She Was Told Her Deep Inflammatory Acne Was Just a Phase…It Lasted 15 Years Without Treatment
- Fact Check: Can Birth Control Pills Clear Acne? Yes, FDA Has Approved 4 Oral Contraceptives for Acne Treatment
- Fact Check: Can Aloe Vera Cure Acne? Soothing Properties Exist but It’s Not a Standalone Acne Treatment
